Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Hajj

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Advances in Radiation Oncology|April 10, 2024
Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry TrialAlexandra Hotca, Kunal K Sindhu, Eric J Lehrer, et al.
Diseases of the Colon and Rectum|December 21, 2023
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative ManagementYael Feferman, Roni Y Rosen, Selim Gebran, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survivalLara Hilal, Marsha Reyngold, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2025
Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal CancerKathryn R Tringale, Kush H Patel, Lara Hilal, et al.
Journal of Clinical Medicine|May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive SurgeryEdward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Blood Advances|June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomasGustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Advances in Radiation Oncology|April 10, 2024
Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry TrialAlexandra Hotca, Kunal K Sindhu, Eric J Lehrer, et al.
Diseases of the Colon and Rectum|December 21, 2023
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative ManagementYael Feferman, Roni Y Rosen, Selim Gebran, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survivalLara Hilal, Marsha Reyngold, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2025
Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal CancerKathryn R Tringale, Kush H Patel, Lara Hilal, et al.
Journal of Clinical Medicine|May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive SurgeryEdward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Blood Advances|June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomasGustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2024
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell LymphomaHarper Hubbeling, Doris Leithner, Emily A Silverman, et al.
Pageof 7